Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00733291 · ClinicalTrials.gov registry record · NA
Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT00733291: Completed NA study, sponsored by Alcon Research.
NCT00733291 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00733291, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate daily disposable lenses inserted out of the blister package versus daily disposable lenses inserted after a pre-soak in Multi-purpose solution FID 107027.
Primary Outcome
Percentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.
Interventions
- DEVICE Nelfilcon A contact lens
- DEVICE Etafilcon A contact lens
- DEVICE FID 107027 solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-02 |
| Phase | NA |
What the finished NCT00733291 record still lists
NCT00733291 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Nelfilcon A contact lens is the first listed.
NCT00733291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00733291 about?
NCT00733291 is a clinical study titled "Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)". The purpose of this study is to evaluate daily disposable lenses inserted out of the blister package versus daily disposable lenses inserted after a pre-soak in Multi-purpose solution FID 107027.
What is the current status of trial NCT00733291?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2008-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00733291?
The interventions under investigation include: Nelfilcon A contact lens (DEVICE), Etafilcon A contact lens (DEVICE), FID 107027 solution (DEVICE).
Who is sponsoring clinical trial NCT00733291?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00733291's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia